Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Meilleure Health International Industry Group Limited ( (HK:2327) ) has provided an announcement.
Meilleure Health International Industry Group Limited has scheduled a board meeting for 27 March 2026 to review and approve the consolidated final results for the year ended 31 December 2025. The board will also consider whether to recommend a final dividend, a decision that could affect shareholder returns and signal management’s confidence in the company’s financial performance.
The announcement also confirms the current composition of the board, which includes executive, non-executive and independent non-executive directors, underscoring the company’s governance structure. This scheduled results meeting and potential dividend recommendation mark an important point in Meilleure Health’s financial calendar and may shape investor expectations around its upcoming annual performance disclosure.
The most recent analyst rating on (HK:2327) stock is a Hold with a HK$0.25 price target. To see the full list of analyst forecasts on Meilleure Health International Industry Group Limited stock, see the HK:2327 Stock Forecast page.
More about Meilleure Health International Industry Group Limited
Meilleure Health International Industry Group Limited is a Bermuda-incorporated company listed in Hong Kong under stock code 2327. The group operates in the broader health industry through its subsidiaries, though this announcement does not detail its specific products, services or geographic market focus.
Average Trading Volume: 1,663,746
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$1.04B
Find detailed analytics on 2327 stock on TipRanks’ Stock Analysis page.